© BusinessWire
20.01.2026
KAPA
LISTED
XASE
Kairos Pharma to Present at 3rd Annual DealFlow Discovery Conference
News Preview
Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it will participate in the DealFlow Discovery Conference, taking place Jan. 28-29, 2026, at the Borgata Hotel in Atlantic City, NJ. Kairos Pharma Chief Scientific Officer Neil Bhowmick will deliver a...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
COYA
LISTED
NASDAQ
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders
News Preview
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to stockholders from Chief Executive Officer Dr. Arun Swaminathan.
Dear Fellow Stockholders,
Coya enters 2026 with strong momentum and a clear sense of pu...
Themefolio
Profiler
Peergroup
© Newsfile
20.01.2026
BIOV
LISTED
CSE
BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC)
News Preview
Study subject Remains in Complete Response for 3 YearsExceeds Expectations in Platinum-Resistant Ovarian Cancer Compared to Standard of Care Single-Agent ChemotherapyVancouver, British Columbia--(Newsfile Corp. - January 20, 2026) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biot...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
20.01.2026
NSPR
LISTED
NASDAQ
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
MIAMI, Jan. 20, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of InspireMD’s Board of Directors approved inducement grants to one (1) new non-executive employee in the aggregat...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© Globe Newswire
20.01.2026
BIOA
LISTED
NASDAQ
BioAge Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, with Plans to Initiate Phase 1b/2a Proof-of-Concept Clinical Trial in Patients with Diabetic Macular Edema in Mid-2026
News Preview
BGE-102 has the potential for therapeutic retinal exposure with oral delivery, reducing treatment burden in ocular indications currently treated with intravitreal therapies...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
AVNS
LISTED
NYSE
Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management
News Preview
ALPHARETTA, Ga., Jan. 20, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) and Siemens Healthineers today announced a strategic co-marketing agreement to advance outpatient and interventional pain care through an integrated ecosystem of imaging and radiofrequency ablation (RFA) technologies....
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
LLY
LISTED
NYSE
Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer
News Preview
INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer,...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
FBLG
LISTED
NASDAQ
FibroBiologics to Present at the DealFlow Discovery Conference
News Preview
HOUSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
QNRX
LISTED
XANS
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
News Preview
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
NVAX
LISTED
NASDAQ
Novavax Announces Entering into a License Agreement with Pfizer
News Preview
Non-exclusive license allows for development by Pfizer to utilize Matrix-M® for up to two disease areas with its productsProvides Novavax with an upfront payment of $30 million with the potential for up to another $500 million in development and sales milestones. In addition to milestone payments, Novavax is eligible to receive high mid-single dig...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
CRVL
LISTED
NASDAQ
CorVel Corporation to Host Live Earnings Release Webcast
News Preview
FORT WORTH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, February 3, 2026, at 11:30 AM Eastern Time....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
20.01.2026
DFTX
LISTED
NASDAQ
Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care
News Preview
Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the launch of Rerouting Minds, an educational campaign aimed at opening perspectives by inc...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
GKOS
LISTED
NYSE
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release fourth quarter and full year 2025 financial results after the market close on Tuesday, February 17, 2026. The company’s management will disc...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
NSRX
LISTED
XASE
Nasus Pharma Announces Positive Interim Results from Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
News Preview
Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to EpiPen®...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
ALHC
LISTED
NASDAQ
Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership
News Preview
Industry veteran brings decades of experience in artificial intelligence, digital transformation and large-scale technology operations to support Alignment’s next phase of growth Industry veteran brings decades of experience in artificial intelligence, digital transformation and large-scale technology operations to support Alignment’s next phase of...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
ECOR
LISTED
NASDAQ
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million
News Preview
ROCKAWAY, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today provided select unaudited preliminary financial guidance for the full year and fourth quarter of 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
LSBCF
LISTED
OTC
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
News Preview
BEIJING, Jan. 20, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced t...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
ACB
LISTED
NASDAQ
Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties
News Preview
NASDAQ | TSX: ACBEuropean grant advances Aurora's unparalleled leadership in cannabis genetics, enhancing its position as a leading medical cannabis companyEDMONTON, AB, Jan. 20, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announces that it has been granted community...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
ACB
LISTED
NASDAQ
Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties
News Preview
NASDAQ | TSX: ACBEuropean grant advances Aurora's unparalleled leadership in cannabis genetics, enhancing its position as a leading medical cannabis companyEDMONTON, AB, Jan. 20, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announces that it has been granted co...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
TECH
LISTED
NASDAQ
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
News Preview
MINNEAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 4, 2026, at 8:00 a.m. CST to review its second quarter fiscal 2026 financial results.Access to the discussion may be obtained as follows:Time: 8:00 a.m. CSTDate: February 4,...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
BMY
LISTED
NYSE
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
News Preview
Bristol Myers Squibb (NYSE: BMY, “BMS”), a global leader in oncology, today announced an agreement with Microsoft, a market leader in AI-powered radiology and clinical workflow technologies, aiming to accelerate early detection of lung cancer.
Through this digital health collaboration, U.S. FDA-cleared radiology AI algorithms will be deployed vi...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
VTRS
LISTED
NASDAQ
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure
News Preview
Builds on Viatris' Scientific Leadership and Commercial Legacy in Cardiovascular Diseases PITTSBURGH, Jan. 20, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced the launch of Inpefa® (sotagliflozin) in the United Arab Emirates (UAE), the first country within the Viatris territories to commercialize the...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
DYN
LISTED
NASDAQ
Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1
News Preview
- Zeleciment basivarsen (z-basivarsen) demonstrated sustained functional improvement across multiple clinical measures in the ongoing ACHIEVE clinical trial -...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
GLAS.A.U
LISTED
NEO
Glass House Brands Announces Accelerated 2026 Expansion Strategy
News Preview
LONG BEACH, Calif. and TORONTO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., announces an acceleration to 2026 expansion plans. These plans are becau...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
CELC
LISTED
NASDAQ
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
News Preview
MINNEAPOLIS, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted for filing its New Drug Application (“NDA”) for gedatolisib in hormone receptor positive (“HR+”...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
MDCX
LISTED
TSX
Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026
News Preview
The Company enters 2026 with Multiple Phase 2 Catalysts, AI-enabled drug development strategy, and regulatory optionality as SKNJCT-003 study approaches database lock, topline clinical data readout and partnering readiness The Company enters 2026 with Multiple Phase 2 Catalysts, AI-enabled drug development strategy, and regulatory optionality as SK...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
RAPT
LISTED
NASDAQ
RAPT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of RAPT Therapeutics, Inc. is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of RAPT Therapeutics, Inc. (NASDAQ: RAPT) to GSK plc for $58.00 per share is fair to RAPT shareholders.
Halper Sadeh encourages RAPT shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
IVVD
LISTED
NASDAQ
Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026
News Preview
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) and the SPEAR Study Group today announced the plan to initiate a Phase 2 clinical trial evaluating monoclonal antibody VYD2311 in individuals with Long COVID or COVID vaccine injury....
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
PLTR
LISTED
NASDAQ
HD Hyundai and Palantir Expand Group-Wide Strategic Partnership
News Preview
HD Hyundai and Palantir Technologies Inc. have strengthened their alliance by reinforcing the strategic partnership. This alliance represents the largest and longest partnership of its kind for Palantir in Korea, significantly expanding the adoption of Palantir’s Foundry and Artificial Intelligence Platform (AIP) across the HD Hyundai Group.
The...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
NTRA
LISTED
NASDAQ
Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the EXPAND clinical trial will be featured in an oral plenary presentation at the SMFM meeting, taking place February 8-13, 2026.
EXPAND is a prospective, blinded clinical trial to develop and validate Fetal Focus. Powered by Natera’s propr...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
RMTI
LISTED
NASDAQ
Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results
News Preview
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced preliminary unaudited financial results for the three months and twelve months ended December 31, 2025.
"Our preliminary fin...
Themefolio
Profiler
Peergroup
© Newsfile
20.01.2026
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness QSR Announces Multi-Unit Franchisee Signs on to Open Their 6th GTA Location at Bloor & Spadina in Toronto
News Preview
Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands, is pleased to announce that its Heal Wellness brand ("Heal") has secured a real estate location at the iconic intersection of Bloor Street West and Spa...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
NHPAP
LISTED
NASDAQ
National Healthcare Properties Announces Confidential Submission of Draft Registration Statement
News Preview
NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (“NHP”) announced today that it has confidentially submitted a draft registration statement on Form S-11 to the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed public offering and initial listing of NHP’s shares of com...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
BOLD
LISTED
NASDAQ
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway
News Preview
BBI-940 IND accepted; initiation of first-in-human clinical trial on track for the first half of 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
NGEN
LISTED
TSX
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
News Preview
NervGen Pharma today announced that the Company will ring the closing bell at the Nasdaq Stock Market on Thursday, January 22, 2026 in New York City...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
TLX
LISTED
ASX
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides an update on its commercial and operational performance for the quarter ended 31 December 2025 (Q4 2025)....
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
TTNP
LISTED
NASDAQ
Digital-First Banking & Payments
News Preview
NEW YORK, NY / ACCESS Newswire / January 20, 2026 / A generation is coming of age with no memory of, or patience for, traditional banking. Their expectation is a financial world that lives on a mobile device - instant, intuitive, and always on. For them, the user interface is the institution.This isn't just a challenge for retail banks; it's a wake...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
4DX
LISTED
ASX
4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
News Preview
Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and moreLOS ANGELES and MELBOURNE, Australia, Jan. 20, 2026 /PRNewswire/ -- 4DMedical, the leader in software-based respiratory imaging technolo...
Themefolio
Profiler
Peergroup
© PR Newswire
20.01.2026
WST
LISTED
NYSE
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
News Preview
Showcasing Leadership in Drug Delivery Solutions and Approaches to Combination Products EXTON, Pa., Jan. 20, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced participation at Pharmapack 2026 in Paris, France to showcase its leadership and expe...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
IBRX
LISTED
NASDAQ
ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA® in BCG-Unresponsive Papillary Bladder Cancer
News Preview
ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B End-of-Phase meeting with the U.S. FDA regarding the Company’s supplemental Biologics License Application (sBLA) for ANKTIVA® (nogapendekin alfa inbakicept) plus Bacillus Calmette-Guérin (BCG) in BCG-unresponsive non-muscle inva...
Themefolio
Profiler
Peergroup
© EQS Newswire
20.01.2026
HIGH
LISTED
XETRA
NuWays AG: Cantourage Group SE | Rating: BUY
News Preview
Original-Research: Cantourage Group SE - from NuWays AG
20.01.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
AYTU
LISTED
NASDAQ
Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
News Preview
EXXUA addresses frequent causes of treatment discontinuation with first-line SSRIs and SNRIsNow commercially available through retail pharmacies and participating Aytu RxConnect® pharmacies to support patient access DENVER, COLORADO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasda...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
AIMD
LISTED
NASDAQ
Ainos to Participate in Fireside Chat with Water Tower Research on January 26, 2026
News Preview
HOUSTON, TEXAS / ACCESS Newswire / January 20, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
RGNT
LISTED
XASE
Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method
News Preview
2 years after treatment, GelrinC-treated patients demonstrated layered cartilage architecture similar to native hyaline cartilage - widely regarded as the gold standard for durable joint functionThis rare outcome in cartilage repair suggests true biological cartilage regeneration, not merely defect fillingUnlike traditional scaffolds, GelrinC limit...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
BAYN
LISTED
XETR
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
News Preview
Bayer and Vanderbilt University Medical Center (VUMC) today announced that they have entered a strategic five-year collaboration agreement to advance innovative therapies from target identification through Investigational New Drug (IND) application. The agreement spans across all indications currently pursued by Bayer, initially focusing on cardio...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
DRMA
LISTED
NASDAQ
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
News Preview
This patent grant follows the Company's U.S. issued patent, covering its Spongilla technology combination as a method to topically treat acneDermata expects to launch a new once-weekly, over-the-counter (OTC) acne treatment system, incorporating its Spongilla technology, in the middle of 2026, first in the U.S.Over 3.3 million people are diagnosed...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
45650
LISTED
XJPX
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
News Preview
Tokyo, Japan and Cambridge, UK, 20 January 2026 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces the formation of a Metabolic Advisory Council comprising world-leading industry experts to provide scientific, clinical, and strategic guidance as Nxera advances its rapidly growing pipeline of next-generation therapies targeti...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
ASBP
LISTED
NASDAQ
Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief
News Preview
New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized anxiety disordersAlprazolam, sold under the brand name Xanax® among others, was the 37th most commonly prescribed medication in the United States, with more than 15.8 million combined branded and generic prescriptions in 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.01.2026
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS20 January 2026 at 08.30 EET ...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
20.01.2026
MRNA
LISTED
NASDAQ
Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following
News Preview
At a median five-year pre-planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA reduced the risk of recurrence or death by 49% (HR=0.510; [95% CI, 0.294-0.887]) compared to KEYTRUDA aloneThe Companies plan to present further data from follow up analyses of the study's primary and second...
Themefolio
Profiler
Peergroup
© Newsfile
19.01.2026
ENBI
LISTED
CSE
Entheon Announces Execution of Business Combination Agreement with Nutravisor
News Preview
Toronto, Ontario--(Newsfile Corp. - January 19, 2026) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered into a definitive business combination agreement (the "Business Combination Agreement") with Nutravisor Inc. ("Nutravisor"), dated January 19, 2026, pursuant t...
Themefolio
Profiler
Peergroup
© PR Newswire
19.01.2026
TLX
LISTED
ASX
Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has accepted the filing of a New Drug Application (NDA) for TLX591-Px (Illuccix®, Kit for the preparati...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.01.2026
AIDR
LISTED
CSE
ROCKET DOCTOR AI INC. ANNOUNCES UPSIZE ON LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT
News Preview
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part,...
Themefolio
Profiler
Peergroup
© Newsfile
19.01.2026
MDS.UN
LISTED
TSX
CORRECTION FROM SOURCE: LDIC Inc. Announces Senior Executive Appointments to Drive the Firm's Next Chapter of Strategic Growth
News Preview
Correction from Source: This press release corrects and replaces the version issued by LDIC Inc. on January 15, 2026, titled “LDIC Inc. Announces Senior Executive Appointments to Drive the Firm’s Next Chapter of Strategic Growth.”Toronto, Ontario--(Newsfile Corp. - January 19, 2026) - LDIC Inc. ("LDIC") announced a series of senio...
Themefolio
Profiler
Peergroup
© ActuNews
19.01.2026
OXUR
LISTED
EURONEXT
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
News Preview
Atlas Special Opportunities, LLC heeft 2 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 50.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1.
Leuven, BELGIUM– 19 januari 2026 – 18u00 CET – Overeenkomstig artikel 15 van de W...
Themefolio
Profiler
Peergroup
© ActuNews
19.01.2026
OXUR
LISTED
EURONEXT
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
News Preview
Atlas Special Opportunities, LLC has converted 2 convertible bonds in Oxurion resulting in a EUR 50,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1].
Leuven, BELGIUM – 19 januari 2026 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.01.2026
ALSAF
LISTED
EURONEXT
SAFE ORTHOPAEDICS FRANCHIT UNE ETAPE STRATEGIQUE : SIGNATURE DE SON PREMIER CONTRAT DE DISTRIBUTION AU BRESIL
News Preview
SAFE ORTHOPAEDICS FRANCHIT UNE ETAPE STRATEGIQUE : SIGNATURE DE SON PREMIER CONTRAT DE DISTRIBUTION AU BRESIL...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.01.2026
GBT
LISTED
EURONEXT
GUERBET : Bilan semestriel du contrat de liquidité
News Preview
Bilan semestriel du contrat de liquidité...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.01.2026
VIRP
LISTED
EURONEXT
Virbac: solid 2025 dynamic with annual revenue up +7.9% at CERS3; with strong momentum in key categories and countries
News Preview
Paul Martingell, Chief Executive Officer statement: ...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
